Very high-power short-duration radiofrequency ablation in patients with typical atrial flutter: rationale and design of the FASD-HP randomized trial

被引：0

作者：

Soria, Laura Valverde ^{[1
,2
]}

Toquero, Jorge ^{[3
]}

Brouzet, Thomas ^{[1
,2
]}

Cano, Laura Garcia ^{[1
,2
]}

Barrios, Ana Garcia ^{[1
,2
]}

Dominguez, Melodie Segura ^{[3
]}

Ramirez, Gloria A. Hermon ^{[3
]}

Ferrer, Raquel Ajo ^{[1
,2
]}

Ferrer, Maria Ajo ^{[1
,2
]}

Concha, Celia Maria Andreu ^{[1
,2
]}

Esteban, Vicente Arrarte ^{[1
,2
]}

Barbie, Angel Sanchez ^{[1
,4
]}

Martinez-Martinez, Juan Gabriel ^{[1
,2
]}

Criado, Alicia Ibanez ^{[1
,2
]}

Criado, Jose Luis Ibanez ^{[1
,2
]}

机构：

[1] Hosp Univ Doctor Balmis, Cardiol Dept, Arrhythmia Unit, Alicante, Spain

[2] Inst Invest Sanitaria Biomed Alicante ISABIAL, Alicante, Spain

[3] Hosp Univ Puerta de Hierro, Cardiol Dept, Arrhythmia Unit, Madrid, Spain

[4] Univ Miguel Hernandez de Elche, Inst Univ Ctr Invest Operat, Stat Math & Informat Dept, Elche, Spain

来源：

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY | 2024年

关键词：

Typical atrial flutter; Cavotricuspid isthmus ablation; Radiofrequency; Very high-power short-duration; PULMONARY VEIN ISOLATION; CATHETER ABLATION; ISTHMUS;

D O I：

10.1007/s10840-024-01969-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BackgroundThe aim of cavotricuspid isthmus (CTI)-dependent flutter ablation is the bidirectional conduction block of the CTI. Very-high-power short-duration (vHPSD) radiofrequency ablation aims to minimize conductive heating and increase resistive heating to create shallower but wider lesions in a very short time, while reducing the risk of collateral tissue damage. Experimental studies have shown that it produces effective transmural lesions with an equal or better safety profile compared to conventional parameters. There are published and ongoing trials studying long-term outcomes of this technique for pulmonary vein isolation, but there is a lack of evidence regarding its use in flutter ablation. Methods and resultsMulticenter 1:1 randomized, single-blind study. Two CTI ablation strategies are compared: (1) conventional treatment arm consisting of 25-40-W applications of unlimited duration until reaching the minimum value of one of the currently accepted lesion markers (Ablation Index > 500 at the anterior half of the CTI and > 400 at the posterior half with CARTO3 system); (2) experimental treatment arm consisting of CTI block using point-by-point applications of very-high-power (90 W) short duration (4 s). The primary objective is to evaluate the non-inferiority of the efficacy and safety of vHPSD ablation in patients undergoing typical flutter ablation. Secondary objectives include comparison of total radiofrequency time, number of applications, number of steam pops, percentage of reconnections, procedure duration, pain during the procedure, and time to flutter recurrence. ConclusionsThe FASD-HP trial is the first clinical trial to investigate the non-inferiority of CTI ablation with vHPSD in patients with typical atrial flutter. Clinical Trial Registration numberThe study was registered at http://www.clinicaltrials.gov (NCT05777850) on March 21, 2023.

引用

页码：497 / 503

页数：7

共 22 条

[1] Brugada J., Katritsis D.G., Arbelo E., Arribas F., Bax J.J., Blomstrom-Lundqvist C., 2019 ESC guidelines for the management of patients with supraventricular tachycardia, ESC Scientific Document Group., 41, 5, pp. 655-720, (2020)
[2] Chen S.A., Chiang C.E., Wu T.J., Tai C.T., Lee S.H., Cheng C.C., Et al., Radiofrequency catheter ablation of common atrial flutter: comparison of electrophysiologically guided focal ablation technique and linear ablation technique, J Am Coll Cardiol, 27, 4, pp. 860-868, (1996)
[3] Hall B., Veerareddy S., Cheung P., Good E., Lemola K., Han J., Et al., Randomized comparison of anatomical versus voltage guided ablation of the cavotricuspid isthmus for atrial flutter, Heart Rhythm, 1, 1, pp. 43-48, (2004)
[4] Deutsch K., Sledz J., Mazij M., Ludwik B., Labus M., Karbarz D., Et al., Maximum voltage gradient technique for optimization of ablation for typical atrial flutter with zero-fluoroscopy approach, Med (Baltimore), 96, 25, (2017)
[5] Begg G.A., O'Neill J., Sohaib A., McLean A., Pepper C.B., Graham L.N., Et al., Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial), PLoS One, 14, 4, (2019)
[6] Zhang T., Wang Y., Han Z., Zhao H., Liang Z., Wang Y., Wu Y., Ren X., Cavotricuspid isthmus ablation using ablation index in typical right atrial flutter, J Cardiovasc Electrophysiol, 30, 11, pp. 2414-2419, (2019)
[7] Reddy V.Y., Grimaldi M., De Potter T., Vijgen J.M., Bulava A., Duytschaever M.F., Et al., Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial, JACC Clin Electrophysiol, 5, 7, pp. 778-786, (2019)
[8] Barkagan M., Contreras-Valdes F.M., Leshem E., Buxton A.E., Nakagawa H., Anter E., High-power and short-duration ablation for pulmonary vein isolation: safety, efficacy, and long-term durability, J Cardiovasc Electrophysiol, 29, 9, pp. 1287-1296, (2018)
[9] Leshem E., Zilberman I., Tschabrunn C.M., Barkagan M., Contreras-Valdes F.M., Govari A., Et al., High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization, JACC Clin Electrophysiol, 4, 4, pp. 467-479, (2018)
[10] Tilz R.R., Sano M., Vogler J., Fink T., Saraei R., Sciacca V., Et al., Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: the fast and furious - AF study, Int J Cardiol Heart Vasc, 26, 35, (2021)

← 1 2 3 →